Metraipolis › archive › dc_23d35f00e2a2

Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal ages — Europe PMC PMID:41286115

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41286115
DOI
10.1038/s41422-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-08T06:32:59.598Z
SHA-256 of the archived text
c39459674404afcba862cc94f1d566ff6c5edcc3dd7a70406062ffdff9c71e69
Stable URL of this page
https://metraipolis.com/documento/dc_23d35f00e2a2

How to cite

Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal ages — Europe PMC PMID:41286115 — Europe PMC (en), https://europepmc.org/article/MED/41286115 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_23d35f00e2a2 (Metraipolis archive dc_23d35f00e2a2, sha256 c39459674404afcba862cc94f1d566ff6c5edcc3dd7a70406062ffdff9c71e69)
BibTeX
@misc{dc23d35f00e2a2,
  title = {Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal ages — Europe PMC PMID:41286115},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41286115},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_23d35f00e2a2; sha256 c39459674404afcba862cc94f1d566ff6c5edcc3dd7a70406062ffdff9c71e69},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41286115. Agents can read the archived copy with the MCP tool read_document.